{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T04:15:44Z","timestamp":1730261744809,"version":"3.28.0"},"reference-count":23,"publisher":"S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMedLife"],"DOI":"10.25122\/jml-2024-0332","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:11:21Z","timestamp":1730200281000},"page":"696-700","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for 3-year mortality in selected patients with Parkinson\u2019s disease from a Romanian cohort"],"prefix":"10.25122","volume":"17","author":[{"given":"\u0218tefan Cristian","family":"Vesa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Pharmacology, Toxicology and Clinical Pharmacology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Sipos-Lascu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Neurosciences, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ionel-Lucian","family":"Stan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Medical Specialties\/Epidemiology, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Emergency Room, Cluj-Napoca Emergency Clinical County Hospital, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicu-Catalin","family":"Draghici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Neurosciences, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"IMOGEN Institute, Emergency Clinical County Hospital Cluj, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lacramioara","family":"Perju-Dumbrav\u0103","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Neurosciences, Iuliu Ha\u021bieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Neurology Clinic, Cluj-Napoca Emergency Clinical County Hospital, Cluj-Napoca, Romania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10755","published-online":{"date-parts":[[2024,7]]},"reference":[{"issue":"8","key":"ref1","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes OB, Storstein A","year":"2017","unstructured":"1. Tysnes OB, Storstein A, Epidemiology of Parkinson\u2019s disease, J Neural Transm (Vienna), 2017;124(8):901-905","journal-title":"J Neural Transm (Vienna)"},{"issue":"3","key":"ref2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management","volume":"5","author":"Chaudhuri KR, Healy DG, Schapira AH","year":"2006","unstructured":"2. Chaudhuri KR, Healy DG, Schapira AH, Non-motor symptoms of Parkinson\u2019s disease: Diagnosis and management, Lancet Neurol, 2006;5(3):235-245","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson\u2019s disease across North America","volume":"4","author":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW","year":"2018","unstructured":"3. Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Prevalence of Parkinson\u2019s disease across North America, NPJ Parkinsons Dis, 2018;421","journal-title":"NPJ Parkinsons Dis"},{"issue":"14","key":"ref4","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","article-title":"What predicts mortality in Parkinson\u2019s disease? A prospective population-based long-term study","volume":"75","author":"Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G","year":"2010","unstructured":"4. Forsaa EB, Larsen JP, Wentzel-Larsen T, Alves G, What predicts mortality in Parkinson\u2019s disease? A prospective population-based long-term study, Neurology, 2010;75(14):1270-1276","journal-title":"Neurology"},{"issue":"1","key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053290","article-title":"Malnutrition in a sample of community-dwelling people with Parkinson\u2019s disease","volume":"8","author":"Sheard JM, Ash S, Mellick GD, Silburn PA","year":"2013","unstructured":"5. Sheard JM, Ash S, Mellick GD, Silburn PA, Malnutrition in a sample of community-dwelling people with Parkinson\u2019s disease, PLoS One, 2013;8(1):","journal-title":"PLoS One"},{"issue":"6","key":"ref6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1001\/archinte.165.6.696","article-title":"Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest","volume":"165","author":"Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V","year":"2005","unstructured":"6. Liperoti R, Gambassi G, Lapane KL, Chiang C, Pedone C, Mor V, Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest, Arch Intern Med, 2005;165(6):696-701","journal-title":"Arch Intern Med"},{"issue":"15","key":"ref7","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-Sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results","volume":"23","author":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P","year":"2008","unstructured":"7. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Movement Disorder Society-Sponsored Revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results, Mov Disord, 2008;23(15):2129-2170","journal-title":"Mov Disord"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression, and mortality","volume":"17","author":"Hoehn MM, Yahr MD","year":"1967","unstructured":"8. Hoehn MM, Yahr MD, Parkinsonism: onset, progression, and mortality, Neurology, 1967;17(5):427-442","journal-title":"Neurology"},{"issue":"3","key":"ref9","first-page":"189","article-title":"\"Mini-Mental State\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein MF, Folstein SE, McHugh PR","year":"1975","unstructured":"9. Folstein MF, Folstein SE, McHugh PR, \"Mini-Mental State\". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res, 1975;12(3):189-198","journal-title":"J Psychiatr Res"},{"issue":"1","key":"ref10","first-page":"1","article-title":"The Leahy Emotional Schemas Scale II (LESS II): Norms and factor structure","volume":"8","author":"Leahy RL","year":"2015","unstructured":"10. Leahy RL, The Leahy Emotional Schemas Scale II (LESS II): Norms and factor structure, Int J Cogn Ther, 2015;8(1):1-16","journal-title":"Int J Cogn Ther"},{"issue":"5","key":"ref11","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/jnnp.2005.075929","article-title":"The Lille Apathy Rating Scale (LARS): A new instrument for detecting and quantifying apathy: validation in Parkinson\u2019s disease","volume":"77","author":"Sockeel P, Dujardin K, Devos D, Deneve C, Dest\u00e9e A, Defebvre L","year":"2006","unstructured":"11. Sockeel P, Dujardin K, Devos D, Deneve C, Dest\u00e9e A, Defebvre L, The Lille Apathy Rating Scale (LARS): A new instrument for detecting and quantifying apathy: validation in Parkinson\u2019s disease, J Neurol Neurosurg Psychiatry, 2006;77(5):579-584","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"ref12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-1781(91)90040-V","article-title":"Reliability and validity of the Apathy Evaluation Scale","volume":"38","author":"Marin RS, Biedrzycki RC, Firinciogullari S","year":"1991","unstructured":"12. Marin RS, Biedrzycki RC, Firinciogullari S, Reliability and validity of the Apathy Evaluation Scale, Psychiatry Res, 1991;38(2):143-162","journal-title":"Psychiatry Res"},{"issue":"3","key":"ref13","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.psychres.2014.06.010","article-title":"Developing a new apathy measurement scale: Dimensional Apathy Scale","volume":"219","author":"Radakovic R, Abrahams S","year":"2014","unstructured":"13. Radakovic R, Abrahams S, Developing a new apathy measurement scale: Dimensional Apathy Scale, Psychiatry Res, 2014;219(3):658-663","journal-title":"Psychiatry Res"},{"issue":"1","key":"ref14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1192\/bjp.167.1.99","article-title":"A scale for the assessment of hedonic tone: the Snaith-Hamilton Pleasure Scale","volume":"167","author":"Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P","year":"1995","unstructured":"14. Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P, A scale for the assessment of hedonic tone: the Snaith-Hamilton Pleasure Scale, Br J Psychiatry, 1995;167(1):99-103","journal-title":"Br J Psychiatry"},{"issue":"1","key":"ref15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1212\/01.WNL.0000147587.04871.27","article-title":"Survival in Parkinson\u2019s disease: thirteen-year follow-up of the DATATOP cohort","volume":"64","author":"Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A","year":"2005","unstructured":"15. Marras C, McDermott MP, Rochon PA, Tanner CM, Naglie G, Rudolph A, Survival in Parkinson\u2019s disease: thirteen-year follow-up of the DATATOP cohort, Neurology, 2005;64(1):87-93","journal-title":"Neurology"},{"issue":"8","key":"ref16","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.parkreldis.2014.04.026","article-title":"Gender differences in non-motor symptoms in early Parkinson\u2019s disease: a 2-year follow-up study on previously untreated patients","volume":"20","author":"Picillo M, Erro R, Amboni M, Longo K, Vitale C, Moccia M","year":"2014","unstructured":"16. Picillo M, Erro R, Amboni M, Longo K, Vitale C, Moccia M, Gender differences in non-motor symptoms in early Parkinson\u2019s disease: a 2-year follow-up study on previously untreated patients, Parkinsonism Relat Disord, 2014;20(8):850-854","journal-title":"Parkinsonism Relat Disord"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"219427","DOI":"10.5402\/2011\/219427","article-title":"Apathy and anhedonia in Parkinson\u2019s disease","volume":"2011","author":"Kaji Y, Hirata K","year":"2011","unstructured":"17. Kaji Y, Hirata K, Apathy and anhedonia in Parkinson\u2019s disease, ISRN Neurol, 2011;2011219427","journal-title":"ISRN Neurol"},{"issue":"10","key":"ref18","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/jnnp.74.10.1308","article-title":"Physical anhedonia in Parkinson\u2019s disease","volume":"74","author":"Isella V, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I","year":"2003","unstructured":"18. Isella V, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I, Physical anhedonia in Parkinson\u2019s disease, J Neurol Neurosurg Psychiatry, 2003;74(10):1308-1311","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref19","article-title":"Antipsychotic drugs could increase mortality in Parkinson\u2019s disease patients","author":"Marotta R","year":"2017","unstructured":"19. Marotta R, Antipsychotic drugs could increase mortality in Parkinson\u2019s disease patients, Pharmacy Times, 2017;","journal-title":"Pharmacy Times"},{"issue":"5","key":"ref20","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1001\/jamaneurol.2016.0031","article-title":"Association of antipsychotic use with mortality risk in patients with Parkinson disease","volume":"73","author":"Weintraub D, Chiang C, Kim HM, Wilkinson J, Marras C, Kales HC","year":"2016","unstructured":"20. Weintraub D, Chiang C, Kim HM, Wilkinson J, Marras C, Kales HC, Association of antipsychotic use with mortality risk in patients with Parkinson disease, JAMA Neurol, 2016;73(5):535-541","journal-title":"JAMA Neurol"},{"issue":"11","key":"ref21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00702-009-0286-7","article-title":"High-dose levodopa therapy and mortality in Parkinson\u2019s disease: a 5-year prospective study","volume":"116","author":"Yoritaka A, Shimo Y, Takanashi M, Fukae J, Hatano T, Nakahara T","year":"2009","unstructured":"21. Yoritaka A, Shimo Y, Takanashi M, Fukae J, Hatano T, Nakahara T, High-dose levodopa therapy and mortality in Parkinson\u2019s disease: a 5-year prospective study, J Neural Transm (Vienna), 2009;116(11):1459-1464","journal-title":"J Neural Transm (Vienna)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson\u2019s disease","volume":"86","author":"Davie CA","year":"2008","unstructured":"22. Davie CA, A review of Parkinson\u2019s disease, Br Med Bull, 2008;86109-127","journal-title":"Br Med Bull"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-7011-7","article-title":"Clinical trial of mirtazapine in the treatment of depression and anxiety in patients with Parkinson\u2019s disease","volume":"253","author":"Barone P, Poewe W","year":"2006","unstructured":"23. Barone P, Poewe W, Clinical trial of mirtazapine in the treatment of depression and anxiety in patients with Parkinson\u2019s disease, J Neurol, 2006;253(Suppl 7\/44-VII\/48):","journal-title":"J Neurol"}],"container-title":["Journal of Medicine and Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-7-2024\/original-article-issue-7-2024\/risk-factors-for-3-year-mortality-in-selected-patients-with-parkinsons-disease-from-a-romanian-cohort\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T11:11:52Z","timestamp":1730200312000},"score":1,"resource":{"primary":{"URL":"https:\/\/medandlife.org\/all-issues\/2024\/issue-7-2024\/original-article-issue-7-2024\/risk-factors-for-3-year-mortality-in-selected-patients-with-parkinsons-disease-from-a-romanian-cohort\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["JMedLife-17-696"],"URL":"https:\/\/doi.org\/10.25122\/jml-2024-0332","relation":{},"ISSN":["1844-3117"],"issn-type":[{"value":"1844-3117","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}